Kodiak Sciences (KOD) Long-Term Investments (2019 - 2020)
Kodiak Sciences (KOD) reported Long-Term Investments of $8.5 million for Q1 2020, down 27.04% quarter-over-quarter from $11.7 million in Q4 2019.
Kodiak Sciences (KOD) Long-Term Investments (2019 - 2020) Analysis & Trends
Kodiak Sciences has reported Long-Term Investments for 2 years, with the latest figure at $8.5 million in Q1 2020.
- For the quarter ending Q1 2020, Long-Term Investments changed N/A year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2020 stood at $8.5 million (changed N/A YoY), and the FY2019 full-year result was $11.7 million, changed N/A from the prior year.
- Long-Term Investments for Q1 2020 stood at $8.5 million, down from $11.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $11.7 million in Q4 2019, with the low at $8.5 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 8.53 Mn |
| Dec 31, 2019 | 11.70 Mn |